Tocilizumab in Covid-19. Reply
- PMID: 33356050
- DOI: 10.1056/NEJMc2032911
Tocilizumab in Covid-19. Reply
Comment on
-
Tocilizumab in Covid-19.N Engl J Med. 2021 Jan 7;384(1):86-87. doi: 10.1056/NEJMc2032911. Epub 2020 Dec 22. N Engl J Med. 2021. PMID: 33356049 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical